Identification of Cryptococcus neoformans in a routine clinical laboratory
โ Scribed by Jennings, Anne ;Bennett, J. E. ;Young, Viola
- Publisher
- Springer-Verlag
- Year
- 1968
- Weight
- 868 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0027-5530
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Forty-one strains of Cryptococcus neoformans were examined after 3 days growth on a fresh and aged medium at pH 5 & pH 7 for comparison of capsule formation. Over one-half of the strains did not form visible capsules on aged medium at pH 5. Serotypes and source of isolation did not correlate with ab
## Three pseudohyphal isolates of Cryptococcus neoformans were inoculated intracranially into mice. Four weeks postinoculation the animals showed no symptoms of disease and the number of viable cells per brain decreased to Zero. Possible roles of pseudohyphal forms of C. neoforroans in the immunol
Bancroftian lilariasis differential reactivitv of anti-sheath antibodies in microtilariae carriers. Z'arasit~Zmmunologv, 16,[321][322][323]
The yeast, Cryptococcus neoformans var. neoformans is a major contributor to the morbidity and mortality experienced by the immunosuppressed population. With a view to providing better treatment, identification of cryptococcal virulence factors is an important goal, with most effort to date directed
Synthetic polyanions have been shown to alter host resistance to infection. The anticryptococcal effect of pyran copolymer was assessed in vivo and in vitro. Pretreatment with pyran copolymer significantly extended mean survival in mice lethally infected with Cryptococcus neoformans when compared to